top of page
Latest News
LanzaTech expands into producing nutritional protein from CO2
US biotech company LanzaTech has announced plans to expand into the alternative protein market, producing a microbial protein from CO2.
Helaina raises $45m to speed-up commercialisation of human bioactive proteins
US biotech start-up Helaina has raised $45 million in a Series B funding round led by investment firm Avidity Partners.
bottom of page